Lymphoma and Myeloma - Cellular Therapy, Efficacy and Safety from Top Trials, Axi-cel, BCMA CAR T Therapy

Play All
06:55

KU ASH 2018 Review: Current Updates in Hematologic Diseases

ASH December 2018 - Lymphoma- Historical Perspective of CAR-T Cell Therapy

FEATURING Frederick L. Locke
  • 210 views
  • March 19, 2019
  • 1
24:51

KU ASH 2018 Review: Current Updates in Hematologic Diseases

ASH December 2018- Lymphoma - Efficacy and Safety from ZUMA 1, JULIET and Other Top Trials

FEATURING Frederick L. Locke
  • 380 views
  • March 19, 2019
  • 1
14:52

KU ASH 2018 Review: Current Updates in Hematologic Diseases

ASH December 2018 - Lymphoma - Axi-cel as Standard of Care and Related Trials

FEATURING Frederick L. Locke
  • 200 views
  • March 19, 2019
  • 1
03:50

KU ASH 2018 Review: Current Updates in Hematologic Diseases

ASH December 2018 - Myeloma - BCMA CAR T Therapy for Refractory Patients

FEATURING Frederick L. Locke
  • 242 views
  • March 19, 2019